Moberg Pharma lowers expectations on main endpoint in ongoing section 3 trial following information in a subset of sufferers By Investing.com
STOCKHOLM, Sept. 13, 2024 /PRNewswire/ -- Moberg Pharma AB (OMX: MOB) broadcasts…
Innate Pharma Pronounces Convention Name and Webcast for First Half 2024 Monetary Outcomes and Business Replace By Investing.com
MARSEILLE, France--(BUSINESS WIRE)--Regulatory Information: Innate Pharma SA (OTC:) (Euronext Paris: IPH; Nasdaq:…
FSD Pharma Declares Share Consolidation and Title Change By Investing.com
Toronto, Ontario--(Newsfile Corp. - August 9, 2024) - FSD Pharma Inc. (NASDAQ:…
aTYR Pharma director Paul Schimmel buys $184k in firm shares By Investing.com
In a current sequence of transactions, Paul Schimmel, a director at aTYR…
Purdue Pharma seeks litigation ceasefire after SCOTUS ruling By Reuters
By Dietrich Knauth NEW YORK (Reuters) - Purdue Pharma on Tuesday requested…
